Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Innovative Biosensors

Request full access

A biosensor system that generates sensitive and specific results with minimal amount of reagents in minutes

Rockville, United StatesFounded 2004Health

About Innovative Biosensors

Innovative Biosensors, Inc. (IBI) is a clinical-stage diagnostics company focused on developing rapid pathogen detection systems. Founded in October 2003 by Joe Hernandez, the company is based in Rockville, Maryland. Hernandez has also founded two other companies, Prolias Technologies and Microlin Bio. In its early days, the company secured an exclusive licensing agreement for the Canary biosensor technology developed at MIT's Lincoln Laboratory. A significant milestone was achieved in January 2004 when IBI entered a research agreement with the U.S. Army Medical Research Institute of Infectious Diseases to develop a SARS test.

The firm develops, manufactures, and markets rapid diagnostic tests designed to detect hazardous materials and harmful substances. The core of its offering is a patented, self-contained biosensor system that utilizes a genetically engineered, cellular-based bioluminescent immunoassay. This technology enables the rapid testing of analytes, providing results in minutes with high sensitivity and specificity. A key feature is that the biosensors can be engineered to detect a single target or multiple targets simultaneously. The system is designed for real-time detection at the point of sampling, requiring only minimal reagents and allowing for operation by minimally-skilled personnel with portable instrumentation. This makes it a cost-effective alternative to traditional laboratory testing.

The company's business model appears to be centered on the development and subsequent licensing of its technology, as evidenced by the agreement to license its BioFlash-E technology to PathSensors, Inc. for biodefense applications. IBI operates in the healthcare and medical diagnostics market, with applications in biodefense, food safety testing, and animal health. Over its history, the company has raised a total of $18.4 million in funding over five rounds from investors including Lightspeed Venture Partners, Life Sciences Partners, and Chart Venture Partners. Its latest funding was a Series B round on March 14, 2012.

Source: Dealroom company data

At a glance

Founded
2004
Headquarters
Rockville, United States
Sector
Health

Innovative Biosensors in the Rockville ecosystem

Live from Dealroom

The Innovative Biosensors office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • The New Markets Growth Fund
  • Maryland Venture Fund
  • Harbert Growth Partners
  • Maryland Department of Business and Economic Development
  • Chart Venture Partners
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Rockville HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Innovative Biosensors on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Innovative Biosensors on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.